Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 43 a 62 di 501
Titolo Data di pubblicazione Autore(i) File
B lymphocytes receptors: a new biological approach for immunofluorescence studies. 1977 CONTE PF ;BOCCADORO M ;PILERI A
A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines 2019 D'Agaro T.; Zucchetto A.; Vit F.; Bittolo T.; Tissino E.; Rossi F.M.; Degan M.; Zaja F.; Bulian P.; Bo M.D.; Ferrero S.; Ladetto M.; Zamo A.; Gattei V.; Bomben R.
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 2018 Bomben, Riccardo; Ferrero, Simone; D'Agaro, Tiziana; Dal Bo, Michele; Re, Alessandro; Evangelista, Andrea; Carella, Angelo Michele; Zamò, Alberto; Vitolo, Umberto; Omedè, Paola; Rusconi, Chiara; Arcaini, Luca; Rigacci, Luigi; Luminari, Stefano; Piccin, Andrea; Liu, Delong; Wiestner, Adrien; Gaidano, Gianluca; Cortelazzo, Sergio; Ladetto, Marco; Gattei, Valter
Bases of sensitivity of light chain amyloidosis to proteasome inhibitors: assessing proteostasis and proteasome stress 2011 L. Oliva; G. Palladini; F. Cerruti; N. Pengo; P. Cascio; R. Sitia; G. Merlini; S. Cenci
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. 2014 Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Pandolfi PP; Saglio G
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial 2011 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL 2010 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 2019 Diop, Fary; Moia, Riccardo; Favini, Chiara; Spaccarotella, Elisa; De Paoli, Lorenzo; Bruscaggin, Alessio; Spina, Valeria; Terzi-di-Bergamo, Lodovico; Arruga, Francesca; Tarantelli, Chiara; Deambrogi, Clara; Rasi, Silvia; Adhinaveni, Ramesh; Patriarca, Andrea; Favini, Simone; Sagiraju, Sruthi; Jabangwe, Clive; Kodipad, Ahad A; Peroni, Denise; Mauro, Francesca R; Del Giudice, Ilaria; Forconi, Francesco; Cortelezzi, Agostino; Zaja, Francesco; Bomben, Riccardo; Rossi, Francesca Maria; Visco, Carlo; Chiarenza, Annalisa; Rigolin, Gian Matteo; Marasca, Roberto; Coscia, Marta; Perbellini, Omar; Tedeschi, Alessandra; Laurenti, Luca; Motta, Marina; Donaldson, David; Weir, Phil; Mills, Ken; Thornton, Patrick; Lawless, Sarah; Bertoni, Francesco; Del Poeta, Giovanni; Cuneo, Antonio; Follenzi, Antonia; Gattei, Valter; Boldorini, Renzo Luciano; Catherwood, Mark; Deaglio, Silvia; Foá, Robin; Gaidano, Gianluca; Rossi, Davide
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. 2006 Larocca A;Piaggio G;Podestà M;Pitto A;Bruno B;Di Grazia C;Gualandi F;Occhini D;Raiola AM;Dominietto A;Bregante S;Lamparelli T;Tedone E;Oneto R;Frassoni F;Van Lint MT;Pogliani E;Bacigalupo A
Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy. 2014 Mateos MV;Bringhen S;Richardson PG;Lahuerta JJ;Larocca A;Oriol A;Boccadoro M;García-Sanz R;Di Raimondo F;Esseltine DL;van de Velde H;Desai A;Londhe A;San Miguel JF;Palumbo A
Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse 2005 MATTEI D; MORDINI N; VIGNA TAGLIANTI R; BRUNO B; RAPEZZI D; GALLAMINI A
Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation 2006 BRUNO B; PATRIARCA F; SORASIO R; MATTEI D; MONTEFUSCO V; PECCATORI J; BONIFAZI F; PETRUCCI MT; MILONE G; GUIDI S; GIACCONE L; ROTTA M; FANIN R; BOCCADORO M; CORRADINI P
BORTEZOMIB, MELPHALAN, PREDNISONE AND THALIDOMIDE (VMPT)VERSUS BORTEZOMIB, MELPHALAN AND PREDNISONE (VMP) INELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS: A PROSPECTIVE,RANDOMIZED, PHASE III STUDY 2009 A. Palumbo; S. Bringhen; D. Rossi; R. Ria; S. Berretta; M. Offidani; F. Patriarca; C. Nozzoli; A. Levi; T. Guglielmelli; G. Benevolo; V. Callea; A.M. Liberati; C. Crippa; N. Di Renzo; L. Catalano; G. De Sabbata; R. Rizzi; C. Feo; R. Mazza; G. Farina; A. Spadano; F. Pisani; L. Podda; G. Aitoro; V. Magarotto; M. Astolfi; F. Di Raimondo; G. Gaidano; M. Boccadoro
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) 2018 Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt
CARDIOVASCULAR EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FIRST-LINE: AN ANALISYS OF THE GIMEMA CML WP 2015 Gugliotta, G; Castagnetti, F; Breccia, M; Stagno, F; Martino, B; Fava, C; Luciano, L; Gozzini, A; Carella, Am; Abruzzese, E; Levato, L; Usala, E; Rossi, G; Bocchia, M; Tiribelli, M; Cavazzini, F; Salvucci, M; Cedrone, M; Trabacchi, E; Binotto, G; Venturi, C; Soverini, S; Cavo, M; Specchia, G; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies 2021 Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara
Carrier detection for prenatal diagnosis of hemophilia A in Italian families. 1992 CAPPELLO N; RESTAGNO G; GARNERONE S; GENNARO C; PERUGINI L; RENDINE S; A. PIAZZA; CARBONARA A
CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA 2018 D'Arena, G; Vitale, C; Rossi, G; Coscia, M; Omede, P; D'Auria, F; Statuto, T; Valvano, L; Ciolli, S; Gilestro, M; Molica, S; Bellesi, S; Topini, G; Panichi, V; Autore, F; Innocenti, I; Musto, P; Deaglio, S; Laurenti, L; Del Vecchio, L
CD34-positive cells: biology and clinical relevance. 1995 CARLO-STELLA C; CAZZOLA M; DE FABRITIIS P; DE VINCENTIIS A; GIANNI AM; LANZA F; LAURIA F; LEMOLI RM; C. TARELLA; ZANON P; TURA S.
Cell cycle analysis in the diagnosis of Fanconi\'s anemia 2000 TIMEUS F; CRESCENZIO N; SARACCO P; LEONE L; PONZIO G; U. RAMENGHI
Mostrati risultati da 43 a 62 di 501
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile